By Gary Weaver
Iversen served as senior vice president at Sarepta, when he led a team that developed drugs to treat Ebola and the related Marburg virus. The company has completed Phase 1 clinical trials with the Ebola drug, known as AVI-7537.
In his presentation “Treatments for Ebola: New Approaches to Infectious Disease,” Iversen will discuss what scientists know about Ebola and how the new drug works. He’ll also discuss how the basis for Sarepta’s approach could signal a new way to treat infectious diseases.
Held on the second Monday of the month, 6 to 8 p.m. in the Old World Deli, 341 2nd Street in Corvallis, Science Pub is sponsored by the Oregon Museum of Science and Industry, the Downtown Corvallis Association, and Terra magazine at Oregon State University.